| Literature DB >> 31392470 |
Sarah Krull Abe1, Eiko Saito2, Norie Sawada1, Shoichiro Tsugane1, Hidemi Ito3,4, Yingsong Lin5, Akiko Tamakoshi6, Junya Sado7, Yuri Kitamura7, Yumi Sugawara8, Ichiro Tsuji8, Chisato Nagata9, Atsuko Sadakane10, Taichi Shimazu1, Tetsuya Mizoue11, Keitaro Matsuo4,12, Mariko Naito13, Keitaro Tanaka14, Manami Inoue15,16.
Abstract
The aim of our study was to assess the association between green tea consumption and all-cause and cause-specific mortality in a pooled analysis of eight Japanese population-based cohort studies. Pooled hazard ratios (HR) and 95% confidence intervals (CI), derived from random effects models, were used to evaluate the associations between green tea consumption, based on self-report at baseline, and risk of all-cause and cause-specific mortality. During a mean follow-up of 17.3 years, among 313,381 persons, 52,943 deaths occurred. Compared with individuals who consumed < 1 cup/day, those in the highest consumption category (≥ 5 cups/day) had a decreased risk of all-cause mortality [the multivariate-adjusted HR was 0.90 (95% CI 0.87-0.94) for men and 0.82 (0.74-0.90) for women]. A similar inverse association was observed for heart disease mortality [HR 0.82 (0.75-0.90) for men, and 0.75 (0.68-0.84) for women], and cerebrovascular disease mortality [HR 0.76 (0.68-0.85) for men, and 0.78 (0.68-0.89) for women]. Among women, green tea consumption was associated with decreased risk of total cancer mortality: 0.89 (0.83-0.96) for the 1-2 cups/day category and 0.91 (0.85-0.98) for the 3-4 cups/day category. Results for respiratory disease mortality were [HR 0.75 (0.61-0.94)] among 3-4 cup daily consumers and [HR 0.66 (0.55-0.79)] for ≥ 5 cups/day. Higher consumption of green tea is associated with lower risk for all-cause mortality in Japanese, especially for heart and cerebrovascular disease. Moderate consumption decreased the risk of total cancer and respiratory disease mortality in women.Entities:
Keywords: Cohort study; Green tea; Japan; Mortality; Pooled analysis
Mesh:
Substances:
Year: 2019 PMID: 31392470 DOI: 10.1007/s10654-019-00545-y
Source DB: PubMed Journal: Eur J Epidemiol ISSN: 0393-2990 Impact factor: 8.082